Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| My Size, Inc.MYSZ · Entity 8556 | Director | December 15, 2025 | December 17, 2025 |
| Steakholder Foods Ltd.STKH · Entity 8436 | Chief Executive Officer | March 18, 2026 | March 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
My Size, Inc.
Report date December 15, 2025 · Filed December 17, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,500 |
Reported balance
After 2025-12-15 transaction · row 1
1 source rowRow 1 · 2025-12-15 · Grant · Acquired 15,000 · Balance 17,500 F1: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan. F2: The restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan.
F2: The restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date.
Steakholder Foods Ltd.
Report date March 18, 2026 · Filed March 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 47,391 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 47,391 F1: Each American Depositary Share represents four thousand (4,000) ordinary shares, no par value. |
Filing footnotes · ownership attribution and instrument terms
F1: Each American Depositary Share represents four thousand (4,000) ordinary shares, no par value.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2025 Filed Dec 17, 2025 21:15 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-028142 · ownership.xml · nonDerivative · entry 1 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,500 F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan. F2 · shares: The restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:10 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 150 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001641172-25-014033 · ownership.xml · derivative · entry 2 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150 Underlying: Common Stock, $.001 par value per share · 150 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:10 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 150 | Not disclosed Strike: $8.72 | Not disclosed |
DisclosureSEC source: 0001641172-25-014033 · ownership.xml · derivative · entry 1 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 150 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:20 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-007020 · ownership.xml · nonDerivative · entry 1 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 F1 · shares: Restricted stock units granted under the My Size, Inc. 2017 Equity Incentive Plan, which vest on January 1, 2025. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 21:02 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 40 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024748 · ownership.xml · derivative · entry 4 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40 Underlying: Common Stock, $.001 par value per share · 40 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 21:02 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 40 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024748 · ownership.xml · derivative · entry 3 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 40 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 21:02 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 1,200 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024748 · ownership.xml · derivative · entry 2 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,200 Underlying: Common Stock, $.001 par value per share · 1,200 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 21:02 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 1,200 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024748 · ownership.xml · derivative · entry 1 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 1,200 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:24 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001213900-20-021624 · ownership.xml · derivative · entry 1 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock, $.001 par value per share · 30,000 shares Expires 2025-08-10 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. All 30,000 options shall vest on November 26, 2020. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 21:53 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 1,000 | Not disclosed Strike: $1.04 | Not disclosed |
DisclosureSEC source: 0001213900-20-014424 · ownership.xml · derivative · entry 6 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock, $.001 par value per share · 1,000 shares Expires 2025-05-29 F4 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 21:53 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 1,000 | Not disclosed Strike: $11.40 | Not disclosed |
DisclosureSEC source: 0001213900-20-014424 · ownership.xml · derivative · entry 5 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 1,000 shares Expires 2024-05-29 F4 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 21:53 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 667 | Not disclosed Strike: $1.04 | Not disclosed |
DisclosureSEC source: 0001213900-20-014424 · ownership.xml · derivative · entry 4 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667 Underlying: Common Stock, $.001 par value per share · 667 shares Expires 2024-09-06 F3 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of September 6, 2024. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 21:53 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 667 | Not disclosed Strike: $13.65 | Not disclosed |
DisclosureSEC source: 0001213900-20-014424 · ownership.xml · derivative · entry 3 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 667 shares Expires 2023-09-06 F3 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of September 6, 2024. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 21:53 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 667 | Not disclosed Strike: $1.04 | Not disclosed |
DisclosureSEC source: 0001213900-20-014424 · ownership.xml · derivative · entry 2 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667 Underlying: Common Stock, $.001 par value per share · 667 shares Expires 2023-07-24 F2 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of July 24, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 21:53 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 667 | Not disclosed Strike: $18.15 | Not disclosed |
DisclosureSEC source: 0001213900-20-014424 · ownership.xml · derivative · entry 1 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 667 shares Expires 2022-07-24 F2 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of July 24, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which all options have vested. Read SEC document |
| May 30, 2019 Filed Jun 4, 2019 01:31 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 15,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009985 · ownership.xml · derivative · entry 1 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock, $.001 par value per share · 15,000 shares Expires 2024-05-30 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. All 15,000 options shall vest on December 31, 2019. Read SEC document |
| September 06, 2018 Filed Jan 30, 2019 21:21 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001213900-19-001447 · ownership.xml · derivative · entry 1 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock, $.001 par value per share · 10,000 shares Expires 2023-09-06 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. All 10,000 options shall vest on September 6, 2019. Read SEC document |
| July 24, 2017 Filed Aug 3, 2017 11:00 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001213900-17-008172 · f4072417kaufman_mysizeinc.xml · derivative · entry 1 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock, $.001 par value per share · 10,000 shares Expires 2022-07-24 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. All 10,000 options shall vest on July 24, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.